Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Merck KGaA team discloses novel PDK1 inhibitors

July 28, 2011

Sanlugen prepares novel cytarabine prodrugs

July 28, 2011

TM-400 receives FDA orphan drug status

July 27, 2011

TH-302 and bevacizumab enter clinical trial in astrocytoma

July 27, 2011

Hutchison MediPharma patents new HGF receptor inhibitors

July 27, 2011

EMA recommends orphan drug status for 4SC's resminostat

July 26, 2011

Orally active histone deacetylase inhibitor displays potent antitumor activity in vivo

July 26, 2011

New cyclin-dependent kinase 9 inhibitors presented by Vichem Chemie Kutato

July 26, 2011

Novartis claims novel agents for treatment of cancer

July 26, 2011

CHMP issues opinion on Zytiga in prostate cancer

July 25, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...